Noun:

కణితి నెక్రోసిస్ కారకం,

tumour necrosis factor's Usage Examples:

caspases and NF-κB, which typically involves interactions with TNF (tumour necrosis factor) cytokine receptors.

finger protein with the cytoplasmic domain of the human type-2 tumour necrosis factor receptor".

"Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2),.

up-regulated by vascular endothelial growth factor and down-regulated by tumour necrosis factor.

Anti‐tumour necrosis factor agents have been proposed as a treatment for macular oedema due to uveitis but a Cochrane Review published in 2018 found no relevant.

crystallography, and determined one of the first structures of a cytokine, tumour necrosis factor (TNF) with David Stuart.

response to the inflammatory mediators interleukin-1 (IL-1) and tumour necrosis factor-alpha and by activated macrophages.

Members of this family are predominantly found in tumour necrosis factor receptor superfamily, member 13b (TACI), and are required for binding.

the release of large amounts of interleukin-1, interleukin-2 and tumour necrosis factor.

Interleukin-1 and tumour necrosis factor are involved in cutaneous hyperalgesia.

"Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis".

"The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games".

"Therapeutic interleukin (IL) 1 blockade normalises increased IL1 beta and decreased tumour necrosis factor alpha and IL10.

Synonyms:

tumor necrosis factor, cytokine, TNF,

Antonyms:

birth, beginning, middle,